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Edited by Vladimir SkulachevAbstract Pyruvate promotes hyperpolarization of the inner
mitochondrial membrane. However, in isolated mitochondria,
pyruvate could participate in a futile cycle leading to mitochon-
drial depolarization. Here, we investigated this paradox in intact
human cells by measuring parameters reﬂecting mitochondrial
activation in response to 1 mM pyruvate and 5 mM glucose.
NAD(P)H levels were elevated similarly by both substrates.
Conversely, pyruvate induced a ﬁrst transient phase of mitochon-
drial depolarization before the establishment of the expected sus-
tained hyperpolarization. This correlated with kinetics of
cytosolic ATP levels exhibiting a ﬁrst phase decrease followed
by an increase. Therefore, pyruvate transiently depolarizes mito-
chondria and reduces ATP in intact cells.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Mitochondria play essential physiological roles in cells and
principally produce the bulk part of cellular ATP through oxi-
dative metabolism. Under aerobic conditions, the majority of
ATP used to maintain cellular homeostasis results from oxida-
tion of the glycolytic product pyruvate. Pyruvate transport
into mitochondria is also important for fatty acid synthesis,
metabolism of some amino acids, and anaplerosis on the whole
[1]. Additional roles of pyruvate include its antioxidant eﬀect
and cardioprotective activity, illustrated by reversal of the
mitochondrial permeability transition [2]. Pyruvate, like other
monocarboxylates, is eﬃciently transported through the
plasma membrane via a proton-linked mechanism mediated
by monocarboxylate transporters (MCT); see review [3]. On
the other hand, transport into the mitochondria is still poorly
characterized [4]. Recently, mitochondrial pyruvate carrier
(MPC) was identiﬁed in Saccharomyces cerevisiae as a 41.9
kDa protein belonging to the mitochondrial carrier family
[5]. However, the corresponding MPC has not been identiﬁed
so far in mammalian mitochondria [6]. Pyruvate is not onlyAbbreviations: DMEM, Dulbeccos modiﬁed Eagles medium; FCCP
carbonyl cyanide p-triﬂuoromethoxyphenylhydrazone; KRBH,Krebs –
Ringer bicarbonate HEPES; MCT, monocarboxylate transporters;
MPC, mitochondrial pyruvate carrier; UCP2, uncoupling protein 2;
143B, human osteorsarcoma cell line 143B.TK
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doi:10.1016/j.febslet.2004.10.088a mitochondrial substrate for pyruvate dehydrogenase but also
for citric acid cycle anaplerosis. Moreover, pyruvate was
shown in isolated mitochondria to participate in a futile cycle,
resulting in mitochondrial uncoupling and concomitant de-
crease in electrochemical proton gradient [7]. In this model,
cytosolic pyruvate anion would be taken up by the pyruvate
carrier together with a proton into mitochondrial matrix.
Then, uncoupling protein (UCP), such as UCP1 expressed in
brown adipose tissue [8], would pump pyruvate anion back
to the cytosol towards the positive mitochondrial proton gra-
dient, thereby completing the futile cycle [7]. Therefore, each
pyruvate cycle results in the transfer of one proton from the
cytosol to the mitochondria, thereby reducing mitochondrial
membrane potential. Other members of the mitochondrial car-
rier family include UCP2, expressed in human and rodent tis-
sues such as spleen, lung, intestine, white adipose tissue and
immune cells [9], and UCP3, expressed mainly in skeletal mus-
cles [8].
Mitochondrial pyruvate metabolism through dehydroge-
nase activity primarily leads to NADH + H+ generation.
NADH is the main carrier of reducing equivalents in mito-
chondria and can be reoxidized by complex I of the electron
transport chain. This results in proton pumping out of the
mitochondrial matrix and hyperpolarization of the mito-
chondrial membrane. The ultimate task of the respiratory
chain is then to form ATP at the expense of the established
proton gradient.
Extrapolated from studies on isolated mitochondria, pyru-
vate could both depolarize and hyperpolarize themitochondrial
membrane according to mechanisms of transfer and metabo-
lism, respectively. In order to clarify the consequences of such
dual eﬀects on mitochondrial activation in intact cells, we mea-
sured NAD(P)H levels, mitochondrial membrane potential,
and ATP levels in the human osteosarcoma cell line 143B. To
our knowledge, it is not known which member of the uncou-
pling protein family is expressed in 143B cells. Therefore, we
analyzed by RT-PCR whether UCP2 or UCP3 is expressed in
143B cells. Pyruvate stimulations, compared to glucose re-
sponses, revealed paradoxical eﬀects of transient depolarization
of the mitochondrial membrane, accompanied by a drop in
cytosolic ATP levels, preceding metabolic activation.2. Materials and methods
2.1. Cell culture
The human osteorsarcoma cell line 143B.TK (143B) was cultured
in a humidiﬁed atmosphere containing 5% CO2 at 37 C in Dulbeccos
modiﬁed Eagles medium (DMEM) supplemented with 5% fetal calf
serum and antibiotics. For all experiments, cells were seeded in 24-well
plates and cultured 3–4 days before use.ation of European Biochemical Societies.
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Metabolic parameters were measured using either ﬂuorescence or
bioluminescence. The 24-well plates were transferred in a thermostated
(37 C) plate-reader set either in the ﬂuorescence or luminescence mode
(Fluostar Optima, BMG Labtechnologies, Oﬀenburg, Germany). Indi-
vidual wells of 24-well plate were recorded sequentially over 20 or 30
min periods and test compounds were added at the indicated times
through automated built-in microinjectors.0
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B2.3. NAD(P)H
NAD(P)H autoﬂuorescence was monitored in Krebs–Ringer bicar-
bonate Hepes buﬀer (KRBH buﬀer; composition in mM: 135 NaCl,
3.6 KCl, 5 NaHCO3, 0.5 NaH2PO4, 0.5 MgCl2, 1.5 CaCl2, and 10
HEPES, pH 7.4) with excitation and emission ﬁlters set at 340 and
460 nm, respectively [10]. After stabilization of the signal for 10 min
in KRBH, 5 mM glucose or 1 mM pyruvate was administered as indi-
cated. NAD(P)H autoﬂuorescence was normalized to pre-stimulation
period by setting the ﬂuorescence as 100%. Control of maximal ﬂuores-
cence changes was performed after the addition of 5 lM rotenone plus
2 lM antimycin-A, added as inhibitors of the electron transport chain
at complexes I and III, respectively.0
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Fig. 1. Eﬀects of glucose or pyruvate on NAD(P)H in 143B cells. (A)
Cells were stimulated at the indicated time with 5 mM glucose (Glc)
and complexes I and III of the electron transport chain were blocked
15 min later by the addition of 5 lM rotenone plus 2 lM antimycin-A
(Ro + AA). (B) Cells were stimulated with 1 mM pyruvate (Pyr)
followed by Ro + AA treatment. Values are means + S.E. of ﬁve2.4. Mitochondrial membrane potential (Dwm) measurements
Mitochondrial membrane potential was measured following cell pre-
incubation in glucose-free medium for 2 h, essentially as described pre-
viously [10,11]. The cells were then incubated in glucose-free KRBH
containing 10 lg/ml of rhodamine-123 (Molecular Probes, Eugene,
OR) for 20 min and washed once with KRBH before starting the
experiment in KRBH. The DWm was monitored with excitation and
emission ﬁlters set at 485 and 520 nm, respectively [10]. Glucose, pyru-
vate, and then the protonophore carbonyl cyanide p-tri-
ﬂuoromethoxyphenylhydrazone (FCCP) were added to each well at
the indicated times. In the present study, the term hyperpolarization
of the inner mitochondrial membrane refers to as mitochondrial state
3 respiration, as phosphorylation occurs.independent experiments.2.5. Cytosolic ATP levels in living 143B cells
Cytosolic ATP levels were monitored in cells expressing the ATP-
sensitive bioluminescent probe luciferase, 1 day after transduction
with the speciﬁc AdCAG-Luc viral construct [12,13]. Following
the preincubation steps as described above, the 24-well plates were
transferred in the plate-reader in the luminometer mode. As a sub-
strate for luciferase, KRBH was supplemented with 500 lM beetle
luciferin (Promega, Madison, WI). Following a 5-min period in glu-
cose-free KRBH, cells were stimulated with the indicated pyruvate
or glucose concentrations and 2 mM NaN3 was added at the end
as a mitochondrial poison.2.6. UCPs expression analysis in 143B cells by reverse transcriptase
PCR (RT-PCR)
Total RNA was extracted from 143B cells using TRIzol reagent
(Invitrogen AG, Basel, Switzerland). Contaminating genomic DNA
was discarded by DNase treatment (Qiagen AG, Hombrechtikon,
Switzerland) before RNA re-extraction by acid phenol:chloroform
and ethanol precipitation. Total RNA (2 lg) was reverse-transcribed
to cDNA using SuperScript reverse transcriptase and random
primers (Invitrogen AG). Primers used to amplify UCP2 and
UCP3 were designed based on GenBank sequences (UCP2:
HSU76367; UCP3 shorter form: NM_022803, UCP3 longer form:
NM_003356) and synthesized by Microsynth (Balgach, Switzerland).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as
control housekeeping gene. GAPDH primers were designed based
on GenBank sequence (BC023632). Negative controls were con-
ducted using primers added to RNA reverse transcription (-RT).
PCR ampliﬁcation conditions were the following: initial denatur-
ation (2 min at 94 C) followed by 40 cycles of 1 min at 94 C,
1 min at 53 C, and 1 min at 72 C with a ﬁnal extension for 7
min at 72 C. PCR products were run in a 2% (w/v) agarose gel
containing ethidium bromide and a 50 bp step ladder used as a mar-
ker. The RT-PCR was performed with three independent RNA
preparations.3. Results
3.1. NAD(P)H
Glucose (5 mM) stimulation evoked rapid and sustained ele-
vations of NAD(P)H relative levels (Fig. 1A). Additive to glu-
cose stimulation, blockage of complexes I and III of the
electron transport chain by rotenone/antimycin-A further in-
creased NAD(P)H levels, thereby revealing the mitochondrial
origin of the signal. When the cells were stimulated with 1
mM pyruvate (Fig. 1B), progressive increases in NAD(P)H
levels were observed, reaching a peak after 2–3 min. Subse-
quently, there was a slow decay in NAD(P)H signal before
the establishment of a plateau phase 5–6 min after pyruvate
addition. Amplitudes and kinetics of the responses to glucose
and pyruvate were similar. These results indicate that mito-
chondrial metabolism was the major contributor of NADH
generation.
3.2. Mitochondrial membrane potential in 143B cells
Stimulation of 143B cells with 5 mM glucose resulted in
hyperpolarization of the mitochondrial membrane (Fig. 2A).
This was revealed by deﬂection of the rhodamine-123 signal
20–25% below basal values recorded in the absence of glucose.
Added subsequently, the protonophore FCCP (1 lM) rapidly
dissipated the electrochemical proton gradient established un-
der state 3 respiration conditions. The DWm was saturated at 5
mM glucose, since higher concentrations did not produce fur-
ther hyperpolarizations (not shown). Remarkably, exposure to
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Fig. 2. Mitochondrial membrane potential (DWm) in 143B cells. (A)
Cells were either kept in glucose free KRBH (Basal) or stimulated with
5 mM glucose (Glc). Ten minutes after stimulation, DWm was collapsed
by the addition of 1 lM FCCP. (B) Pyruvate (Pyr) at diﬀerent
concentrations (0.4, 1 and 3 mM) was added 10 min before FCCP.
Values are means + S.E. of ﬁve (A) and one out of ﬁve (B) independent
experiments.
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Fig. 3. Cytosolic ATP levels of 143B cells. Bioluminescence was
monitored from 143B cells expressing luciferase. (A) Cells were
stimulated with 5 mM glucose (Glc) and 10 min later 2 mM NaN3
was added as an inhibitor of the respiratory chain. (B) Stimulation
with 1 mM pyruvate (Pyr) followed by 2 mM NaN3 addition 10 min
later. Values are means + SE of four independent experiments.
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phase of the mitochondrial membrane lasting 45–60 s. The
amplitudes of pyruvate-evoked depolarization were dose
dependent with signal rises of 5%, 15%, and 22% above base-
line at 0.4, 1, and 3 mM pyruvate, respectively. These paradox-
ical depolarization phases were followed by the expected
sustained hyperpolarization responses. The rate of hyperpolar-
ization evoked by 1 mM pyruvate was about half the rate of
glucose-induced hyperpolarization. As a control, FCCP dissi-
pated the electrochemical proton gradient. Hyperpolarization
was maximal already at 1 mM pyruvate and drastically re-
duced upon 3 mM pyruvate exposure. Therefore, at 3 mM
pyruvate, activation of the electron transport chain could not
eﬃciently compensate depolarization.
3.3. Cytosolic ATP levels
Cytosolic ATP levels were monitored in 143B cells express-
ing luciferase. Cells responded to 5 mM glucose stimulation
with a sustained 100% elevation of cytosolic ATP levels (Fig.
3A). Subsequent blockage of complex IV by the addition of
2 mM NaN3 resulted in a drop in ATP levels. When the cells
were exposed to 1 mM pyruvate (Fig. 3B), a transient decrease
in cytosolic ATP levels during the ﬁrst min was observed
(11%, P < 0.05). This was followed by sustained rise in
ATP levels up to 62% above basal levels after 9–10 min pyru-
vate stimulation. Again, NaN3 addition abolished subsequentmitochondrial ATP production. Exposure to 1 lM FCCP
abrogated both transient drop and successive elevation of
ATP evoked by pyruvate (not shown).
3.4. UCPs expression in 143B cells
We analyzed the putative expression of the two UCPs ex-
pressed in non-brown adipose tissues, namely UCP2 and
UCP3. Agarose gel of RT-PCR products revealed that
UCP2 is expressed in the human osteosarcoma 143B cell line
(Fig. 4), as demonstrated by the ampliﬁcation of a correspond-
ing 190 bp fragment (lane UCP2). This positive band did not
result from genomic DNA contamination, as evidenced by
negative PCR using UCP2 primers in the absence of RT.
UCP3 expression was not detected in 143B cells.4. Discussion
It is commonly expected that both glucose and pyruvate
stimulations lead to hyperpolarization of the inner mitochon-
drial membrane due to generation of electrochemical proton
gradient. However, we observed that pyruvate induced a ﬁrst
transient phase of mitochondrial depolarization before the
establishment of the expected sustained state 3 hyperpolariza-
tion. It has been previously reported that pyruvate exerts
uncoupling activity in isolated mitochondria [7,14]. Our study
demonstrates such phenomenon in intact human cells and its
consequences on cytosolic ATP. As pyruvate is not able to
cross the mitochondrial membrane due to its negative charge,
it has to be taken up with a proton (symport) by a monocar-
Fig. 4. UCPs expression in 143B cells. RT-PCR products using
primers for UCP2, UCP3, and GAPDH were analyzed on agarose gel.
RNA derived cDNA with UCP2 primers (lane UCP2), UCP3 primers
(lane UCP3), and GAPDH primers (lane GAPDH). RNA not reverse
transcribed with UCP2 primers (lane-RT) and RT mix solution
without primers (lane mix).
Fig. 5. Model for mitochondrial pyruvate cycle (adapted from [7]): as
pyruvate is negatively charged and not able to cross the mitochondrial
membrane, it is either taken up with a proton by a pyruvate carrier
(symport) or exchanged by a hydroxide anion (antiport). Once
pyruvate enters the mitochondrial matrix, it could follow the oxidative
pathway (a). Alternatively, pyruvate could be driven through an
alternative pathway, being pumped back into the intermembrane space
(b), possibly through UCP2. Therefore, the complete cycle would
promote the transient depolarization of the inner mitochondrial
membrane (c).
P.B.M. de Andrade et al. / FEBS Letters 578 (2004) 224–228 227boxylate transporter, such as MPC [5], or exchanged for a
hydroxide (antiport). This would cause transient depolariza-
tion of the mitochondrial membrane as shown in this study.
Consequently, oxidative phosphorylation might be transiently
uncoupled when the electrochemical proton gradient across
the inner mitochondrial membrane is utilized to drive solute
transport, e.g., pyruvate.
Pyruvate stimulation evoked a ﬁrst phase of lowered cyto-
solic ATP levels, lasting for approximately 1 min. This should
be correlated with the observed ﬁrst phase depolarization of
the mitochondrial membrane. Kinetic comparisons revealed
that concomitant with second phase state 3 hyperpolarization,
ATP levels increased up to 62% above basal levels. As ex-
pected, ATP production upon glucose stimulation was higher
(50%) than in response to pyruvate, the latter bypassing gly-
colysis. The diﬀerence between glucose and pyruvate induced
ATP generation was greater than the only theoretical cytosolic
contribution, indicating important leak of glucose derived lac-
tate. Glucose stimulation neither induced ﬁrst phase mitochon-
drial membrane depolarization nor signiﬁcant initial ATP level
drop. This could be explained by the actual intracellular con-
centrations of glucose-derived pyruvate, probably dynamically
lower than the one imposed by direct pyruvate addition.
NADH produced in the cytosol cannot be directly trans-
ferred to the mitochondria and, therefore, shuttle systems
transport reducing equivalents carried by NADH + H+ into
the mitochondrial matrix [15]. The involvement of these shut-
tles might account for the immediate build up of NAD(P)H
levels upon glucose stimulation compared to delayed pyruvate
response. However, the predominant contribution of NADH
signal was of mitochondrial origin as indicated by responses
to inhibitors of the electron transport chain. Interestingly,
there was no initial decrease of NAD(P)H levels upon pyruvate
stimulation. This supports the concept that pyruvate-induced
depolarization directly implicated the inner mitochondrial
membrane rather than pyruvate catabolism.
Pyruvate can be oxidized in mitochondria, leading to citric
acid cycle feeding, generation of reducing equivalents, and
activation of the electron transport chain resulting in hyperpo-
larization of the inner mitochondrial membrane. However,pyruvate can also be transported by UCP1 [7], the latter acting
as an anion uniporter and mild mitochondrial uncoupler. Ta-
ken as a whole, pyruvate is primarily transported into the
mitochondria by speciﬁc carrier (e.g., MPC). Then, the pyru-
vate fraction that is not oxidized might leave the mitochondrial
matrix via UCP1, thereby completing a futile cycle. These
events would account for the paradoxical eﬀect reported here,
i.e., pyruvate-induced mitochondrial depolarization. We have
identiﬁed here UCP2 expression in the human osteosarcoma
cell line 143B. Possibly, UCP2 might participate in the pyru-
vate transport across the inner mitochondrial membrane, act-
ing as an alternative pathway for non-oxidized pyruvate (Fig.
5). However, further studies should be conducted to investigate
putative UCP2 contribution to pyruvate-induced transient
mitochondrial depolarization.
We conclude that the electroneutral pyruvate uptake by the
mitochondria accounts for a paradoxical transient depolariza-
tion of the inner mitochondrial membrane, associated with a
drop in cytosolic ATP.
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